Tvardi Therapeutics Is A Clinical Stage Biotechnology Company Based In Sugar Landtexasfounded In 2017The Company Focuses On Developing Oral Small Molecule Therapies That Target Stat3A Molecule Involved In Cancer And Fibrosistvardi Is Committed To Addressing Significant Unmet Needs In These Areasled By A Team Of Experienced Entrepreneursscientistsand Physicians The Company Specializes In Stat3 Inhibitorswith A Pipeline That Includes Tti 101 And Tti 109These Therapies Are Designed To Treat Conditions Such As Idiopathic Pulmonary Fibrosis And Hepatocellular Carcinomatvardi Is Currently Conducting Phase 2 Clinical Trials For These Inhibitorstargeting Diseases With High Unmet Medical Needsthe Company Is Listed On The Nasdaq Under The Ticker Symbol Tvrd
No conferences found for this company.
| Company Name | Tvardi Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
